KALA BIO, INC. Stock Issued During Period, Value, Issued for Services
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- KALA BIO, INC. stock issued during period, value, issued for services for the quarter ending 2024-12-31 was $0.00.
- KALA BIO, INC. stock issued during period, value, issued for services for the quarter ending 2024-09-30 was $0.00.
- KALA BIO, INC. stock issued during period, value, issued for services for the quarter ending 2024-06-30 was $0.00.
- KALA BIO, INC. stock issued during period, value, issued for services for the quarter ending 2024-03-31 was $29.00K.
- KALA BIO, INC. stock issued during period, value, issued for services for fiscal 2025 was $1.55M, a 5255.17% increase from fiscal 2024.
- KALA BIO, INC. stock issued during period, value, issued for services for fiscal 2024 was $29.00K.
| Period end | Stock Issued During Period, Value, Issued for Services 3 month | Stock Issued During Period, Value, Issued for Services 12 month |
|---|---|---|
| 2025-12-31 | $1.55M 10-K · filed 2026-04-15 | |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | $29.00K 10-K · filed 2026-04-15 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-19 | |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | |
| 2024-03-31 | $29.00K 10-Q · filed 2025-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |